NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes Oct 24, 2023 08:00AM
NexImmune (NEXI) Announces 1-for-25 Reverse Stock Split Oct 18, 2023 11:30AM
NexImmune Announces 1-for-25 Reverse Stock Split Oct 18, 2023 11:30AM
NexImmune (NEXI) Announces 53% Workforce Cut, Terminates CFO Aug 31, 2023 05:15PM
NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update Nov 14, 2022 04:01PM